Virtual Medicinal Product (VMP) - Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets

Navigation

Name Details

Name Start Date End Date
Name Current Name Emtricitabine 200mg / Rilpivirine 25mg / Tenofovir disoproxil 245mg tablets Start Date 02-04-2025 End Date
Previous Name Previous Name Generic Eviplera 200mg/25mg/245mg tablets Start Date 01-06-2012 End Date 01-04-2025
Abbreviated Name Abbreviated Name Emtr 200mg/Rilpivirine 25mg/Tenofovir disoproxil 245mg tab Start Date 02-04-2025

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
1.0
UDFS UOM
tablet
Unit Dose UOM
tablet

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Oral
Form
Oral tablet
Ontology Form/Route
tablet.oral
Name Basis
Other

Codes

ATC Code
J05AR08
BNF Start Date End Date
Current BNF 05030100 Start Date 04-04-2022 End Date
Previous BNF 05030100 Start Date 04-12-2012 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
20594611000001108 01-06-2012

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Emtricitabine Based on Ingredient Substance 200 mg
Rilpivirine hydrochloride Based on Base Substance Rilpivirine 25 mg
Tenofovir disoproxil Based on Ingredient Substance 245 mg

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
30 tablet